Latest Innovations
The Latest Life Science Innovations Changing Patients Lives
Click the social share buttons below to keep your network up to date on the latest life science innovations changing patients lives.
Sign Up - Newsletter
Sign up for our regular newsletter to receive the latest trends and news from the California Biotechnology Industry
The Latest on Life Science Innovations
The California Biotechnology Foundation is committed to keeping you up to date about the latest breakthroughs in biotech treatments and the impact of one of California’s largest industries in the state and beyond. This newsletter edition, as of September 25, 2024, brings you updates directly from the forefront of medical innovation. Among the notable advancements featured are:
-
The FDA approved Novartis’s targeted therapy for certain early-stage breast cancers, significantly expanding the number of patients who will have access to this type of drug.
-
Gilead Science’s new drug, lenacapavi, was found to be 96% effective in preventing HIV infections.
-
UC Davis School of Medicine’s external research awards exceeded $1 billion for research on ultra-rare diseases and most common ones, like diabetes, cancer and heart disease.